Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles

Lassa fever is a frequently severe human disease that is endemic to several countries in West Africa. To date, no licensed vaccines are available to prevent Lassa virus (LASV) infection, even though Lassa fever is thought to be an important disease contributing to mortality and both acute and chroni...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Infect Dis
Main Authors: Kainulainen, Markus H., Spengler, Jessica R., Welch, Stephen R., Coleman-McCray, JoAnn D., Harmon, Jessica R., Scholte, Florine E. M., Goldsmith, Cynthia S., Nichol, Stuart T., Albariño, César G., Spiropoulou, Christina F.
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6744324/
https://ncbi.nlm.nih.gov/pubmed/31152662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz284
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki